Evolus, Inc. Cash and Equivalents

Quick Answer

Evolus, Inc. reported Cash and Equivalents of $53.83 million for fiscal year 2025.

Evolus, Inc. Cash and Equivalents — Annual History

Fiscal Year Cash and Equivalents YoY Change
2025 $53.83M -38.1%
2024 $86.95M +38.4%
2023 $62.84M +16.5%
2022 $53.92M -63.1%
2021 $146.26M +42.6%
2020 $102.56M -6.7%
2019 $109.89M +18.0%
2018 $93.16M
2017 $0.00

Quarterly Cash and Equivalents

Quarter Ending Cash and Equivalents YoY QoQ
September 30, 2025 $43.52M -48.8% -29.5%
June 30, 2025 $61.74M -34.1% -9.1%
March 31, 2025 $67.89M -30.0% -21.9%
December 31, 2024 $86.95M +38.4% +2.3%
September 30, 2024 $85.03M +119.8% -9.2%
June 30, 2024 $93.67M +124.6% -3.4%
March 31, 2024 $96.96M +208.2% +54.3%
December 31, 2023 $62.84M +16.5% +62.4%
  • Evolus, Inc. showed a decrease of -38.1% in Cash and Equivalents compared to the prior fiscal year.
  • The most recent figure is from Evolus, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment